Drug information for SLO-BID
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
CAPSULE, EXTENDED RELEASE; ORAL
100MG
Discontinued
THEOPHYLLINE
Theophylline
SANOFI AVENTIS US
87892
CAPSULE, EXTENDED RELEASE; ORAL
200MG
Discontinued
THEOPHYLLINE
Theophylline
SANOFI AVENTIS US
87893
CAPSULE, EXTENDED RELEASE; ORAL
300MG
Discontinued
THEOPHYLLINE
Theophylline
SANOFI AVENTIS US
87894
CAPSULE, EXTENDED RELEASE; ORAL
50MG
Discontinued
THEOPHYLLINE
Theophylline
SANOFI AVENTIS US
88269
CAPSULE, EXTENDED RELEASE; ORAL
75MG
Discontinued
THEOPHYLLINE
Theophylline
SANOFI AVENTIS US
89539
CAPSULE, EXTENDED RELEASE; ORAL
125MG
Discontinued
THEOPHYLLINE
Theophylline
SANOFI AVENTIS US
89540
Drug Adverse Effects information for SLO-BID
Role code
Indications
Reaction
# Reports
SS
ASTHMA
ANAEMIA
1
SS
TYPE 2 DIABETES MELLITUS
ANAEMIA
2
Ads by Google